Cytisine, N-formyl-

Details

Top
Internal ID 4a9032cf-8c6b-40d8-90ab-ae63f16dee7f
Taxonomy Alkaloids and derivatives > Lupin alkaloids > Cytisine and derivatives
IUPAC Name 6-oxo-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-diene-11-carbaldehyde
SMILES (Canonical)
SMILES (Isomeric)
InChI InChI=1S/C12H14N2O2/c15-8-13-5-9-4-10(7-13)11-2-1-3-12(16)14(11)6-9/h1-3,8-10H,4-7H2
InChI Key PCYQRXYBKKZUSR-UHFFFAOYSA-N
Popularity 24 references in papers

Physical and Chemical Properties

Top
Molecular Formula C12H14N2O2
Molecular Weight 218.25 g/mol
Exact Mass 218.105527694 g/mol
Topological Polar Surface Area (TPSA) 40.60 Ų
XlogP 0.10
Atomic LogP (AlogP) 0.42
H-Bond Acceptor 3
H-Bond Donor 0
Rotatable Bonds 1

Synonyms

Top
6-oxo-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-diene-11-carbaldehyde
CHEMBL1433686
DCA00706
NCGC00017402-02
NCGC00142626-01

2D Structure

Top
2D Structure of Cytisine, N-formyl-

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9872 98.72%
Caco-2 + 0.8529 85.29%
Blood Brain Barrier + 0.9500 95.00%
Human oral bioavailability + 0.6286 62.86%
Subcellular localzation Mitochondria 0.8077 80.77%
OATP2B1 inhibitior - 0.8624 86.24%
OATP1B1 inhibitior + 0.9504 95.04%
OATP1B3 inhibitior + 0.9518 95.18%
MATE1 inhibitior - 0.5023 50.23%
OCT2 inhibitior - 0.6750 67.50%
BSEP inhibitior - 0.9021 90.21%
P-glycoprotein inhibitior - 0.9791 97.91%
P-glycoprotein substrate - 0.7845 78.45%
CYP3A4 substrate - 0.5000 50.00%
CYP2C9 substrate - 0.6048 60.48%
CYP2D6 substrate - 0.8351 83.51%
CYP3A4 inhibition - 0.8310 83.10%
CYP2C9 inhibition - 0.9070 90.70%
CYP2C19 inhibition - 0.9025 90.25%
CYP2D6 inhibition - 0.9644 96.44%
CYP1A2 inhibition - 0.9046 90.46%
CYP2C8 inhibition - 0.8458 84.58%
CYP inhibitory promiscuity + 0.6679 66.79%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.9300 93.00%
Carcinogenicity (trinary) Non-required 0.6684 66.84%
Eye corrosion - 0.9807 98.07%
Eye irritation - 0.8412 84.12%
Skin irritation - 0.7899 78.99%
Skin corrosion - 0.9581 95.81%
Ames mutagenesis - 0.5500 55.00%
Human Ether-a-go-go-Related Gene inhibition - 0.5096 50.96%
Micronuclear + 0.7600 76.00%
Hepatotoxicity + 0.6724 67.24%
skin sensitisation - 0.8621 86.21%
Respiratory toxicity + 0.7111 71.11%
Reproductive toxicity + 0.6667 66.67%
Mitochondrial toxicity + 0.8375 83.75%
Nephrotoxicity + 0.7539 75.39%
Acute Oral Toxicity (c) III 0.6026 60.26%
Estrogen receptor binding - 0.6843 68.43%
Androgen receptor binding - 0.5226 52.26%
Thyroid receptor binding - 0.6650 66.50%
Glucocorticoid receptor binding - 0.6652 66.52%
Aromatase binding + 0.5193 51.93%
PPAR gamma + 0.5465 54.65%
Honey bee toxicity - 0.8665 86.65%
Biodegradation - 0.7250 72.50%
Crustacea aquatic toxicity + 0.6700 67.00%
Fish aquatic toxicity - 0.6700 67.00%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
CHEMBL4159 Q99714 Endoplasmic reticulum-associated amyloid beta-peptide-binding protein 25118.9 nM
Potency
via CMAUP

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 94.64% 95.56%
CHEMBL5697 Q9GZT9 Egl nine homolog 1 90.38% 93.40%
CHEMBL1907588 P02708 Acetylcholine receptor; alpha1/beta1/delta/gamma 90.09% 98.33%
CHEMBL2581 P07339 Cathepsin D 90.05% 98.95%
CHEMBL4026 P40763 Signal transducer and activator of transcription 3 87.55% 82.69%
CHEMBL5805 Q9NR97 Toll-like receptor 8 86.63% 96.25%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 85.24% 96.09%
CHEMBL3137262 O60341 LSD1/CoREST complex 84.65% 97.09%
CHEMBL1293249 Q13887 Kruppel-like factor 5 82.19% 86.33%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 81.34% 99.23%

Cross-Links

Top
PubChem 589870
NPASS NPC244256
ChEMBL CHEMBL1433686
LOTUS LTS0240022
wikiData Q104252924